• Return to Headlines

Medicines Comp Shares Down 19.5% Since SmarTrend's Sell Call (MDCO)

By Amy Schwartz

SmarTrend identified a Downtrend for Medicines Comp (NASDAQ:MDCO) on May 17th, 2017 at $45.29. In approximately 3 months, Medicines Comp has returned 19.47% as of today's recent price of $36.47.

In the past 52 weeks, Medicines Comp share prices have been bracketed by a low of $30.80 and a high of $55.95 and are now at $36.47, 18% above that low price. The 200-day and 50-day moving averages have moved 0.07% higher and 0.47% higher over the past week, respectively.

The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Medicines Comp.

Log in and add Medicines Comp (MDCO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights medicines comp

Ticker(s): MDCO